(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202103 | 202003 | % Var | 202103 | 202003 | % Var | 202103 | 202003 | % Var | |
| Sales | 25159.60 | 24838.80 | 1.29 | 110559.30 | 110256.60 | 0.27 | 110559.30 | 110256.60 | 0.27 |
| Other Income | 660.70 | 2099.10 | -68.52 | 1290.90 | 4751.90 | -72.83 | 1290.90 | 4751.90 | -72.83 |
| PBIDT | 4911.20 | 4453.20 | 10.28 | 21731.50 | 23828.00 | -8.80 | 21731.50 | 23828.00 | -8.80 |
| Interest | 123.10 | 113.80 | 8.17 | 406.20 | 525.90 | -22.76 | 406.20 | 525.90 | -22.76 |
| PBDT | 4788.10 | 4339.40 | 10.34 | 21325.30 | 15710.00 | 35.74 | 21325.30 | 15710.00 | 35.74 |
| Depreciation | 1250.10 | 1247.80 | 0.18 | 5028.30 | 5187.50 | -3.07 | 5028.30 | 5187.50 | -3.07 |
| PBT | 3538.00 | 3091.60 | 14.44 | 16297.00 | 10522.50 | 54.88 | 16297.00 | 10522.50 | 54.88 |
| TAX | 374.40 | 838.70 | -55.36 | 3710.80 | 3247.00 | 14.28 | 3710.80 | 3247.00 | 14.28 |
| Deferred Tax | 236.70 | -263.20 | -189.93 | 82.30 | -373.50 | -122.03 | 82.30 | -373.50 | -122.03 |
| PAT | 3163.60 | 2252.90 | 40.42 | 12586.20 | 7275.50 | 72.99 | 12586.20 | 7275.50 | 72.99 |
| Equity | 907.40 | 906.00 | 0.15 | 907.40 | 906.00 | 0.15 | 907.40 | 906.00 | 0.15 |
| PBIDTM(%) | 19.52 | 17.93 | 8.88 | 19.66 | 21.61 | -9.05 | 19.66 | 21.61 | -9.05 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1904.65 |
| Dr. Reddys Labs. | 1374.55 |
| Cipla | 1458.45 |
| Zydus Lifesciences | 1141.00 |
| Lupin | 2476.10 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: